Back to homepage

Tag "India Covid patients"

Glenmark to start trial combining 2 anti-viral drugs on India Covid patients

Glenmark to start trial combining 2 anti-viral drugs on India Covid patients

🕔16:21, 26.May 2020

New Delhi, May 26  Glenmark Pharmaceuticals announced on Tuesday that it will commence another new Phase 3 clinical trial on a combination of two anti-viral drugs Favipiravir and Umifenovir in hospitalized patients of moderate COVID-19 in India. Glenmark has received

Read Full Article

Search the Website

Advertiser’s Logo